Nordea Investment Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-7,537
Closed -$5.42M 929
2020
Q3
$5.42M Sell
7,537
-8,524
-53% -$6.2M 0.01% 436
2020
Q2
$11.1M Buy
+16,061
New +$9.27M 0.01% 409

Other funds holding CDLX

Nordea Investment Management's CDLX Position: Q4 2020 in Review

Nordea Investment Management sold out of Cardlytics (CDLX) in Q4 2020, closing a stake of 7,537 shares — an estimated $5.42M sold.

Nordea Investment Management first reported a position in CDLX in Q2 2020 and held it in 2 quarters. The position peaked at $11.1M in Q2 2020. 195 funds tracked by Wall St. Rank hold CDLX as of Q4 2020.

  • Nordea Investment Management reported no remaining Cardlytics position as of Q4 2020 after selling out during the quarter.
  • Nordea Investment Management sold 7,537 Cardlytics shares in Q4 2020, an estimated $5.42M.
  • Nordea Investment Management first reported a position in Cardlytics in Q2 2020 and held it in 2 quarters.
  • Nordea Investment Management's Cardlytics position peaked at $11.1M in Q2 2020.
  • 195 funds tracked by Wall St. Rank held Cardlytics as of Q4 2020.

Based on Nordea Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.